FIGURE

Figure 1

ID

ZDB-FIG-220104-133

Publication

Zhou et al., 2021 - Simultaneous Tests of Theaflavin-3,3'-digallate as an Anti-Diabetic Drug in Human Hepatoma G2 Cells and Zebrafish (Danio rerio)

Other Figures

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

All Figure Page

Back to All Figure Page

Figure 1

The effect of TF3 on HepG2 cell viability (A) and cell morphology (B). Control, DMEM medium culture; TF3, DMEM medium containing different concentrations of TF3 (1, 5, 10, 20, 50, 100 μM) treating for 24 h. ** p < 0.01 versus control group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nutrients